It is about having a provider who can assess whether the compound is working, whether the dose is appropriate for the specific injury and patient profile, and whether the response at weeks four and eight warrants continuing, adjusting, or pausing
Sinha R, Sinha I, Calcagnotto A, Trushin N, Haley JS, Schell TD, Richie JP Jr
A lack of this vitamin may result in nail ridges, brittle and thinning hair, and hyperpigmentation of the skin
A REGISTRY-BASED CASE-CONTROL STUDY Guri Hagberg 1,2 , Hkon Ihle-Hansen 3,4 , Tamar Abzhandadze 2,5 , Malin Reinholdsson 2,5 , Adam Viktorisson 2,6 , Henri Pesonen 7 , Hege Ihle-Hansen 4 , Katharina Stibrant Sunnerhagen 2,6 1 Oslo Stroke Unit, Department of Neurology, Oslo University Hospital, Oslo, Norway, 2 Institute of Neuroscience and Physiology, Section for Clinical Neuroscience and Rehabilitation, Gothenburg University, Gothenburg, Sweden, 3 Department of Medicine, Brum Hospital- Vestre Viken Hospital Trust, Drammen, Norway, 4 Research department Brum Hospital, Vestre Viken Hospital Trust, Drammen, Norway, 5 Department of Occupational Therapy and Physiotherapy, Sahlgrenska University Hospital, Gothenborg, Sweden, 6 Neurocare, Sahlgrenska University Hospital, Gothenburg, Sweden, 7 Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway Background and Aims: Patient reported outcome measures (PROMs) could expose meaningful differences but are scarcely investigated in acute stroke trials
